Discovery of pyrazolo[1,5-a]pyrimidin-7-amine derivatives as mTOR kinase domain inhibitors: Hit to lead optimization

被引：0

作者：

Deng, Yongqi ^{[1
]}

Sun, Binyuan ^{[1
]}

Shipps, Gerald ^{[1
]}

Matthew, Richards ^{[1
]}

Meng, Zhaoyang ^{[1
]}

Windsor, Williama ^{[1
]}

Zeng, Hongbo ^{[1
]}

Long, Brian ^{[1
]}

Xiao, Li ^{[1
]}

机构：

[1] Merck Res Labs, Drug Discovery, Boston, MA 02115 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2014年 / 248卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

165-MEDI

引用

页数：1

共 50 条

[21] Discovery and structure - activity relationship exploration of pyrazolo [1,5-a]pyrimidine derivatives as potent FLT3-ITD inhibitors
Chen, Yun
Bai, Gang
Li, Yan
Ning, Yi
Cao, Sufen
Zhou, Jinpei
Ding, Jian
Zhang, Huibin
Xie, Hua
Duan, Wenhu
BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 48
[22] Highly selective C3-sulfenylation and C3-selenylation of 3-iodo-5-arylpyrazolo[1,5-a]pyrimidin-7-amine in water
Sang, Tian
Jia, Fan
He, Jing
Liu, Yan
Liu, Jichang
Liu, Ping
JOURNAL OF MOLECULAR STRUCTURE, 2023, 1292
[23] Efficacy and Tolerability of Pyrazolo[1,5-a]pyrimidine RET Kinase Inhibitors for the Treatment of Lung Adenocarcinoma
Mathison, Casey J. N.
Chianelli, Donatella
Rucker, Paul V.
Nelson, John
Roland, Jason
Huang, Zhihong
Yang, Yang
Jiang, Jiqing
Xie, Yun Feng
Epple, Robert
Bursulaya, Badry
Lee, Christian
Gao, Mu-Yun
Shaffer, Jennifer
Briones, Sergio
Sarkisova, Yelena
Galkin, Anna
Li, Lintong
Li, Nanxin
Li, Chun
Hua, Su
Kasibhatla, Shailaja
Kinyamu-Akunda, Jacqueline
Kikkawa, Rie
Molteni, Valentina
Tellew, John E.
ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (04): : 558 - 565
[24] Advances in pyrazolo[1,5-a]pyrimidines: synthesis and their role as protein kinase inhibitors in cancer treatment
Iorkula, Terungwa H.
Jude-Kelly Osayawe, Osasere
Odogwu, Daniel A.
Ganiyu, Latifat Oluwatobi
Faderin, Emmanuel
Awoyemi, Raymond Femi
Akodu, Busayo Odunayo
Ifijen, Ikhazuagbe Hilary
Aworinde, Omowunmi Rebecca
Agyemang, Peter
Onyinyechi, Odo Lovelyn
RSC ADVANCES, 2025, 15 (05) : 3756 - 3828
[25] Synthesis and Bioactivity of Pyrazolo[1,5-a]pyrimidine Derivatives as Novel c-Met Inhibitors
Ni, Chunyan
Zhang, Yuting
Zhao, Yu
Zhu, Li
CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2012, 32 (12) : 2294 - 2299
[26] Synthesis of pyrazolo[1,5-a][1,3,5]triazine derivatives as inhibitors of thymidine phosphorylase
Sun, Lingyi
Bera, Hriday
Chui, Wai Keung
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 65 : 1 - 11
[27] Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors:: Improvements in physical properties enhance cellular activity and pharmacokinetics
Fraley, ME
Rubino, RS
Hoffman, WF
Hambaugh, SR
Arrington, KL
Hungate, RW
Bilodeau, MT
Tebben, AJ
Rutledge, RZ
Kendall, RL
McFall, RC
Huckle, WR
Coll, KE
Thomas, KA
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (24) : 3537 - 3541
[28] Preparation and optimization of pyrazolo[1,5-a]pyrimidines as new potent PDE4 inhibitors
Le Roux, Jacques
Leriche, Caroline
Chamiot-Clerc, Philippe
Feutrill, John
Halley, Frank
Papin, David
Derimay, Nathalie
Mugler, Christelle
Grepin, Claudine
Schio, Laurent
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (02) : 454 - 459
[29] Discovery of pyrazolo[1,5-a]pyrimidine-based Pim inhibitors: A template-based approach
Dwyer, Michael P.
Keertikar, Kartik
Paruch, Kamil
Alvarez, Carmen
Labroli, Marc
Poker, Cory
Fischmann, Thierry O.
Mayer-Ezell, Rosemary
Bond, Richard
Wang, Yan
Azevedo, Rita
Guzi, Timothy J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (22) : 6178 - 6182
[30] Discovery of 3-pyrazolyl-substituted pyrazolo[1,5-a]pyrimidine derivatives as potent TRK inhibitors to overcome clinically acquired resistance
Gong, Yi
Wu, Feng-Xu
Wang, Ming-Shu
Xu, Hong-Chuang
Zhuo, Lin-Sheng
Yang, Guang-Fu
Huang, Wei
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 241

← 1 2 3 4 5 →